Building on its recognition as the RCCN for North Africa, Egypt has achieved another milestone: 24 Egyptian experts have been appointed as instructors for the Africa CDC Two-Year Biomanufacturing Fellowship Program—representing 40–50 percent of the total instructors across Africa.
This unprecedented representation underscores Egypt’s depth of expertise, institutional excellence, and commitment to regional capacity building.
The selected instructors come from leading entities within the EVMA RCCN network, including: The Egyptian Drug Authority (EDA), Faculty of Pharmacy – Cairo University, VACSERA, BioGeneric Pharma (BGP) and Vaccines and Biotechnology City (VBC).
Together, they represent the full value chain of vaccine manufacturing—production, regulation, and academia—forming a comprehensive national ecosystem for biomanufacturing advancement.
The instructors will deliver technical modules, mentor fellows, and support hands-on industrial learning across Africa CDC’s fellowship tracks. Their involvement ensures harmonization of biomanufacturing standards, fosters cross-country collaboration, and accelerates Africa’s collective journey toward vaccine self-reliance.
This milestone also reinforces the success of Egypt’s integrated approach under EVMA and RCCN, aligning national efforts with Africa CDC’s workforce expansion strategy for 2040.
Through its dual leadership in training program design and expert instruction, Egypt continues to shape the future of African vaccine manufacturing. These efforts demonstrate a unified national commitment—linking government, industry, and academia—to empower Africa’s scientific community and build a resilient, self-sustaining health manufacturing ecosystem.
With its fellowship programs and instructor network, Egypt stands at the forefront of Africa’s biomanufacturing revolution—transforming vision into capacity, and capacity into impact
يجب أنت تكون مسجل الدخول لتضيف تعليقاً.
Need help? Our team is just a message away